RLAY

NASDAQ HEALTHCARE

Relay Therapeutics Inc

$18.87

-$0.02 (-0.11%)

Live quote

52w: $3.89 – $21.27

Loading chart…

P/E Ratio—

P/B Ratio4.65

EV/EBITDA—

Debt/Equity—

ROE-31.06%

ROIC—

Revenue Growth53.44%

Gross Margin—

Relay Therapeutics, Inc. is a clinical-stage precision drug company. The company is headquartered in Cambridge, Massachusetts.

Create a free account to add RLAY to a portfolio and watch your P/L update in real time.

Custom screens, valuation models and backtesting are coming to Pro.